Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicOXFD
Date11/2013
Raised$64M
Post IPO Valuation

General Information

Websiteoxfordimmunotec.com
Blogfacebook.com/home...
Twitter@TBDiagnosis
CategoryMedical
Phone+44(0)1235 442780
Emailmarketing@oxfordi...
Employees79
Founded2002
DescriptionTB Testing Company

Offices

Oxford Immunotec HQ
115D Milton Park
Abingdon
Oxfordshire, OX14 4RZ, GBR
Oxford Immunotec D&M
94C Milton Park
Abingdon
Oxfordshire, OX14 4RY, GBR
Oxford Immunotec Inc.
2 Mount Royal Avenue, Suite 100
Marlborough, MA, MA 01792
USA

People

Funding

Tags

Oxford Immunotec

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company’s first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Recent Milestones

Videos

Screenshots

Oxford Immunotec screenshot
Above: Oxford Immunotec Ltd
Uploaded: 3/11/10

Stock Price

Sources

  1. Oxford Immunotec gets 7m [pounds sterling] to broaden reach of TB test. (accessmylibrary.com) [edit]
  2. Oxford Immunotec Completes $40M Financing (oxfordimmunotec.com) [edit]
  3. Oxford Immunotec, Ltd.: Series D $26M (onbiovc.com) [edit]
  4. Oxford Immunotec Raises $28M in Equity Financing (finsmes.com) [edit]
  5. Oxford Immunotec Sets IPO Range at $13-$15 Per Share (pevc.dowjones.com) [edit]
Edit This Page
Last Edited 11/22/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy